Considerable evidence support that increased ASCT2 expression is closely related to poor prognosis, such as non-small cell lung cancer [10], colorectal cancer [9], prostate cancer [19] and gastric cancer [20]. This evidence concerns the gene SLC1A5 and Familial prostate cancer.